Margaret Ives on the BPCIA Dispute

View "Apotex Sets Stage for Next Fed. Circ. BPCIA Dispute"

Margaret Ives wrote “Apotex Sets Stage for Next Fed. Circ. BPCIA Dispute”  in Intellectual Property Law360, where she discusses Apotex Inc. and Amgen Inc.’s Biologics Price Competition and Innovation Act’s dispute.  She also explains the background and timeline of the case, and uses Amgen’s previous case with Sandoz Inc. as a point of contrast with the current Apotex case.